Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: results from a systematic review of the literature

This SIOG NAH webinar was organised on March 10 at 7.00 am PST (Vancouver), 10.00 am EST (Toronto), 16.00 CET (Paris).

Speaker

Dr Chloé Herledan

Dr Chloé Herledan is a pharmacist at Lyon Sud University Hospital (France) and PhD student at the University of Lyon. She is specialized in oncology pharmacy, including chemotherapy compounding, experimental drug management, and clinical pharmacy with a special interest in geriatric oncology. Her research focus on the development and evaluation of multidisciplinary interventions to optimize drug therapy in older patients with cancer.

Recording

Â